Meningococcal B vaccine (4CMenB): the journey from research to real world experience-Reference-Cited by-同舟云学术

Meningococcal B vaccine (4CMenB): the journey from research to real world experience

Published:2018-12-02 Issue:12 Volume:17 Page:1111-1121
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Rappuoli Rino¹^ORCID,Pizza Mariagrazia²,Masignani Vega³,Vadivelu Kumaran⁴

Affiliation:

1. Chief Scientist & Head of External Research and Development, GSK, Siena, Italy

2. Senior Scientific Director, Bacterial Vaccines, Chief Scientist & Head of External Research and Development, Siena, Italy

3. Discovery Project Leader, Research and Development Centre, Siena, Italy

4. Vaccine Development Leader, Research and Development Centre, Rockville, MD, USA

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://tandfonline.com/doi/pdf/10.1080/14760584.2018.1547637

Reference81 articles.

1. European Center for Disease Prevention and Control. Surveillance report. Surveillance of invasive bacterial diseases in Europe. 2012. [Cited 2018 Jun 26]. Available from: http://ecdc.europa.eu/en/publications/Publications/Surveillance%20of%20IBD%20in%20Europe%202012.pdf

2. Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report. 2016. [Cited 2018 May 07]. Available from: https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf.

3. A universal vaccine for serogroup B meningococcus

4. Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent population;The Lancet Regional Health - Western Pacific;2024-02

2. Neisseria gonorrhoeae vaccines: a contemporary overview;Clinical Microbiology Reviews;2024-01-16

3. Promising developments in gonococcal vaccines;Current Opinion in Infectious Diseases;2023-12-04

4. Outer Membrane Vesicle Vaccine Platforms;BioDrugs;2023-10-05

5. Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness;Expert Review of Vaccines;2023-08-25